influenza
highli
contagi
diseas
pose
health
threat
human
accord
onlin
report
center
diseas
control
prevent
thousand
peopl
hospit
influenzarel
ill
influenza
season
present
vaccin
antivir
drug
major
countermeasur
influenza
viru
infect
howev
vaccin
need
conduct
annual
bodi
immun
respons
vaccin
declin
time
influenza
virus
constantli
chang
besid
influenza
vaccin
suitabl
peopl
sever
allerg
chicken
egg
moreov
current
antivir
drug
includ
neuraminidas
na
protein
inhibitor
would
limit
appear
resist
virus
fact
apart
viral
factor
host
factor
also
import
process
influenza
viru
infect
pattern
recognit
receptor
prr
detect
pathogenassoci
molecular
pattern
pamp
includ
influenza
viru
result
product
type
interferon
ifn
type
ifn
exhibit
nonredund
effect
type
ifn
inhibit
viru
replic
boost
adapt
immun
limit
acut
lung
injuri
therefor
novel
antiinfluenza
viru
drug
target
host
factor
worth
discov
group
previous
util
restraint
stress
disrupt
type
ifn
secret
increas
suscept
influenza
viru
base
model
success
evalu
antiinfluenza
efficaci
sever
tradit
chines
medicin
natur
product
appl
polyphenol
sarcandra
glabra
extract
redun
inject
isati
indigotica
tradit
medicin
wide
appli
clinic
china
treat
viral
diseas
hepat
influenza
enceph
recent
studi
also
show
antivir
activ
japanes
enceph
viru
rabi
influenza
virus
indirubin
bisindol
alkaloid
main
activ
ingredi
isati
indigotica
mak
colleagu
prove
antivir
activ
indirubin
influenza
inhibit
product
chemokin
regul
activ
normal
cell
express
secret
human
bronchial
epitheli
cell
infect
influenza
viru
chang
laboratori
show
indirubin
antivir
effect
japanes
enceph
viru
block
viru
attach
howev
vitro
studi
vivo
studi
requir
indirubin
also
show
antiinflammatori
effect
report
inhibit
inflammatori
reaction
delayedtyp
hypersensit
previou
studi
suggest
indirubin
potenti
agent
influenza
viru
underli
mechan
retain
unclear
purpos
restraintstress
mous
model
along
stress
hormon
corticosteron
cort
load
cell
model
employ
investig
antiinfluenza
effect
indirubin
explor
mechan
infect
intranas
inocul
bodi
weight
chang
surviv
mice
group
monitor
daili
day
illustr
figur
averag
bodi
weight
mice
viru
group
began
decreas
day
drop
minimum
day
gain
weight
day
howev
averag
bodi
weight
mice
stressviru
group
recov
day
compar
stressviru
group
oseltamivir
indirubinh
indirubinl
treatment
could
significantli
maintain
bodi
weight
restraintstress
mice
infect
influenza
viru
morbid
mous
estim
weight
decreas
shown
figur
compar
viru
group
stressviru
group
observ
higher
morbid
vs
compar
stressviru
group
oseltamivir
indirubinh
indirubinl
reduc
morbid
p
p
respect
data
indic
role
indirubin
allevi
morbid
stress
mice
infect
influenza
viru
also
support
improv
behavior
chang
alter
respir
ruf
fur
calcul
surviv
estim
mortal
mice
group
shown
figur
significantli
lower
surviv
rate
observ
stressviru
group
compar
viru
group
p
comparison
oseltamivir
indirubinh
indirubinl
treatment
significantli
improv
surviv
rate
p
p
respect
sever
pneumonia
primarili
account
morbid
mortal
influenza
infect
lung
tissu
remov
day
influenza
viru
challeng
detect
patholog
chang
shown
figur
edema
extravas
red
blood
cell
seen
fresh
lung
tissu
mice
stressviru
group
h
e
stain
show
alveoli
fill
exud
congest
vessel
observ
lung
tissu
stress
mice
follow
infect
contrast
oseltamivir
indirubinh
indirubinl
significantli
allevi
lung
pathogenes
slight
lesion
estim
pulmonari
edema
calcul
lung
index
group
shown
figur
lung
index
normal
group
increas
p
viru
group
increas
p
stressviru
group
nevertheless
oseltamivir
indirubinh
indirubinl
notabl
decreas
p
p
respect
proinflammatori
respons
essenti
earli
control
influenza
viral
replic
howev
excess
inflamm
result
tissu
damag
cytotox
lung
western
blot
employ
detect
level
proinflammatori
cytokin
shown
figur
figur
express
level
lung
stressviru
group
significantli
increas
compar
viru
group
howev
modest
attenu
occur
group
indirubinh
indirubinl
treatment
meanwhil
indirubinh
indirubinl
decreas
product
lung
tissu
follow
infect
p
contrast
indirubin
treatment
induc
elev
product
pleiotrop
cytokin
limit
inflammatori
respons
lung
tissu
stress
mice
viru
infect
p
result
show
indirubin
navig
balanc
proinflammatori
respons
protect
pneumonia
associ
influenza
infect
restraintstress
mice
nucleoprotein
np
level
indic
replic
state
influenza
viru
shown
figur
np
protein
express
lung
stressviru
group
increas
remark
p
compar
viru
group
howev
indirubin
treatment
obvious
reduc
np
protein
level
p
influenza
viru
recogn
host
sensor
result
type
ifn
secret
type
ifn
includ
activ
innat
antivir
respons
suppress
viru
replic
besid
could
induc
express
interferon
induc
transmembran
inhibit
viral
rna
transloc
nuclear
replic
appreci
present
studi
protein
express
obvious
decreas
lung
tissu
stress
mice
follow
infect
inhibit
indirubin
treatment
figur
next
explor
indirubin
induc
product
paid
attent
mav
signal
detect
viru
rna
rigi
essenti
prr
within
cell
lead
aggreg
mav
signal
result
activ
interferon
regulatori
factor
respect
stimul
product
proinflammatori
cytokin
type
ifn
studi
found
protein
express
mav
phosphoryl
declin
protein
express
increas
lung
mice
stressviru
group
p
compar
viru
group
indirubin
treatment
elev
mav
express
promot
phosphoryl
lung
tissu
figur
figur
contrari
express
reduc
indirubin
figur
indic
intracellular
pathway
tolllik
receptor
also
involv
investig
potenti
effect
indirubin
reduc
influenza
suscept
vitro
cort
h
treatment
use
simul
stress
cell
np
protein
level
measur
concentr
indirubin
select
base
influenc
cell
viabil
normal
cell
cortload
cell
data
shown
western
blot
result
show
indirubin
inhibit
influenza
viru
replic
enhanc
express
antivir
protein
figur
indirubin
chosen
explor
influenc
indirubin
mav
antivir
signal
protein
express
mav
remark
declin
cortload
cell
follow
influenza
viru
infect
indirubin
treatment
improv
product
p
figur
figur
nevertheless
indirubin
treatment
reduc
np
protein
level
cell
treat
cort
plu
viru
figur
also
detect
chang
np
mav
level
immunofluoresc
result
coincid
western
blot
figur
figur
sting
protein
locat
endoplasm
reticulum
reticular
well
defin
control
dna
virus
recent
associ
mav
signal
pathway
rna
viru
infect
discov
studi
sting
predict
candid
target
indirubin
surflexdock
program
dock
score
polar
score
shape
similar
tanimoto
coeffici
shown
figur
carbonyl
indirubin
act
hydrogen
bond
acceptor
form
hbond
nh
residu
sting
carbonyl
indirubin
transform
hydroxyl
group
act
hydrogen
bond
donor
form
hbond
n
residu
sting
addit
two
hydrophob
group
benzen
ring
favor
confirm
role
sting
antiviru
effect
indirubin
use
cortload
cell
model
result
western
blot
show
sting
protein
express
increas
cell
follow
infect
howev
declin
cell
pretreat
cort
rescu
indirubin
treatment
figur
hand
found
sting
knockdown
small
interf
rna
sirna
abrog
improv
effect
indirubin
protein
express
p
figur
mav
locat
outer
membran
mitochondria
form
aggreg
activ
morpholog
function
mitochondria
play
import
role
mav
signal
transduct
involv
chang
mitochondri
morpholog
overexpress
report
induc
small
fragment
mitochondria
fact
known
counteract
mav
signal
data
suggest
protein
express
increas
lung
tissu
mice
cell
infect
intriguingli
level
promot
stress
treatment
mice
cort
treatment
cell
prevent
indirubin
administr
figur
figur
next
examin
chang
mitochondri
morpholog
immunofluoresc
confoc
imag
indic
small
fragment
mitochondria
occur
cortload
cell
without
influenza
viru
infect
disrupt
locat
mav
furthermor
indirubin
treatment
maintain
mitochondri
morpholog
mav
express
locat
furthermor
mitochondri
membran
potenti
mmp
measur
flow
cytometri
stain
shown
figur
remark
increas
green
fluoresc
intens
cell
follow
viru
infect
aggrav
cort
pretreat
howev
indirubin
treatment
significantli
prevent
decreas
mmp
clinic
elder
adult
suscept
influenza
viru
death
occur
elder
popul
recent
studi
found
iavinfect
monocyt
elder
human
impair
product
antivir
interferon
report
restraint
stress
suppress
nk
activ
decreas
number
lymphocyt
cell
alter
antibodi
product
inflammatori
respons
previou
studi
shown
restraint
stress
disrupt
type
ifn
secret
increas
suscept
influenza
viru
increas
risk
die
durat
complic
parallel
clinic
featur
suscept
popul
activ
axi
import
indic
stress
respons
result
cort
secret
studi
found
cortinduc
immun
suppress
underli
mechan
increas
mortal
previou
studi
util
cort
establish
influenza
suscept
model
cell
therefor
employ
restraintstress
mice
model
cortload
cell
model
evalu
protect
effect
indirubin
influenza
suscept
firstli
evalu
influenc
morbid
mice
caus
influenza
infect
stress
mice
result
indic
mice
suffer
sick
certain
proport
intranas
administr
influenza
viru
restraint
stress
significantli
aggrav
morbid
contrast
indirubin
remark
improv
sick
symptom
moreov
also
apprais
effect
indirubin
health
statu
mice
chang
bodi
weight
sever
previou
report
demonstr
influenza
viru
infect
bodi
weight
mice
decreas
first
increas
afterward
although
time
period
decreas
depend
type
amount
influenza
viru
well
host
factor
data
indic
indirubin
maintain
bodi
weight
mice
rel
stabl
statu
prevent
sharp
drop
earli
day
caus
stress
plu
viru
secondli
evalu
influenc
indirubin
mortal
mice
result
show
indirubin
significantli
suppress
declin
surviv
rate
caus
influenza
infect
stress
mice
thirdli
antiinfluenza
effect
indirubin
also
notic
cortload
cell
model
reflect
reduc
np
level
vitro
vivo
observ
demonstr
improv
effect
indirubin
reduc
suscept
caus
stress
evid
shown
excess
inflammatori
infiltr
lung
tissu
injuri
main
factor
account
high
mortal
follow
influenza
viru
infect
result
indic
indirubin
treatment
could
mitig
lung
edema
inflammatori
cell
infiltr
caus
influenza
viru
infect
stress
mice
host
infect
influenza
viru
macrophag
neutrophil
recruit
lung
produc
proinflammatori
cytokin
aid
immun
respons
limit
influenza
viru
spread
howev
cytokin
storm
excess
chemokin
cytokin
may
lead
lung
damag
studi
anim
model
found
excess
level
contribut
develop
pulmonari
lesion
correl
acut
inflammatori
respons
mediat
acut
pulmonari
inflammatori
patholog
report
kaiser
lab
found
relat
symptom
score
temperatur
valu
experiment
human
infect
antiinflammatori
cytokin
mediat
lung
inflamm
control
effector
cell
moreov
block
activ
cours
infect
lead
overproduct
proinflammatori
mediat
result
show
indirubin
treatment
lessen
product
enhanc
product
lung
tissu
influenzainfect
mice
load
stress
result
found
indirubin
exert
antiinflamm
effect
result
indic
indirubin
amelior
viral
pneumonia
restraintstress
mice
upon
influenza
viru
infect
pamp
recogn
viru
prr
result
type
ifn
secret
type
ifn
stimul
express
gene
term
isg
play
import
role
antivir
state
among
isg
restrict
influenza
viral
replic
block
cell
membran
fusion
earli
step
vivo
studi
found
critic
protect
host
influenza
viru
result
restrict
morbid
mortal
present
studi
indirubin
resist
decreas
protein
express
induc
influenza
infect
stress
mice
cortload
cell
explor
effect
indirubin
product
relat
wellknown
antirna
viru
pathway
name
detect
viral
rna
rigi
activ
bind
mav
locat
outer
membran
mitochondria
interact
induc
aggreg
mav
follow
activ
signal
eventu
lead
product
proinflammatori
cytokin
type
ifn
studi
indirubin
treatment
significantli
restor
express
mav
promot
phosphoryl
stress
mice
cortload
cell
infect
influenza
viru
unexpectedli
level
reduc
indirubin
treatment
point
pathway
may
involv
depress
effect
tolllik
receptor
inflammasom
although
specul
remain
prove
coincid
efficaci
indirubin
lung
damag
upon
defin
role
mavsmedi
gener
antiviru
effect
indirubin
took
deeper
insight
mechan
purpos
employ
surflexdock
program
molecular
dock
sting
found
candid
target
indirubin
sting
resid
endoplasm
reticulum
act
mitochondri
cofactor
mav
signal
cortload
cell
util
sirna
western
blot
techniqu
confirm
key
role
sting
activ
mav
signal
induc
indirubin
morpholog
function
mitochondria
essenti
aggreg
mav
interact
mav
sting
examin
chang
mitochondria
morpholog
function
well
mitochondria
dynamicrel
gtpase
confoc
imag
flow
cytometri
suggest
indirubin
treatment
inhibit
fragment
mitochondria
declin
mmp
caus
influenza
infect
cortload
cell
find
line
previou
two
report
research
koshiba
laboratori
prove
mmp
correl
mavsmedi
antivir
signal
dissip
mmp
reduc
antivir
respons
mitochondria
chang
morpholog
membran
fission
fusion
play
decis
role
process
previou
research
found
mitochondri
morpholog
drastic
chang
overexpress
result
small
fragment
mitochondria
present
studi
restraint
stress
cort
respect
induc
elev
protein
express
mice
cell
chang
suppress
indirubin
treatment
result
well
explain
indirubin
recov
mitochondri
network
promot
mav
signal
overal
result
demonstr
indirubin
decreas
suscept
viru
reduc
product
proinflammatori
cytokin
allevi
pneumonia
restraintstress
mice
base
restraintstress
mice
model
cortload
cell
model
indirubin
found
maintain
morpholog
function
mitochondria
ensur
product
mediat
mav
signal
follow
infect
figur
indirubin
batch
obtain
nation
institut
food
drug
control
beij
china
oseltamivir
batch
purchas
yichang
changjiang
pharmaceut
co
ltd
wuhan
china
cort
purchas
sigma
mo
usa
influenza
viru
donat
prof
jianxin
chen
south
china
agricultur
univers
guangzhou
china
new
viral
stock
passag
allanto
caviti
specif
pathogenfre
fertil
egg
viru
fluid
kept
use
median
lethal
dose
measur
mice
amount
appli
anim
experi
relat
influenza
viru
median
tissu
cultur
infect
dose
measur
cell
amount
appli
vitro
experi
specificpathogenfre
male
kunm
mice
threeweekold
g
obtain
guangdong
medic
laboratori
anim
center
guangzhou
china
approv
id
scxk
anim
rais
plastic
cage
bed
materi
corn
straw
live
cycl
equal
light
dark
rel
humid
anim
experi
conform
anim
care
use
committe
jinan
univers
approv
well
nation
institut
health
guid
care
use
laboratori
anim
edit
usa
first
anim
experi
mice
distribut
random
six
group
normal
viru
stressviru
oseltamivirstressviru
oseltamivir
two
indirubin
group
describ
indirubinhstressviru
indirubinlstressviru
respect
oseltamivir
indirubin
administ
oral
mice
seven
day
mice
group
oral
treat
equal
volum
water
first
day
administr
mice
except
normal
viru
group
restrict
ventil
plastic
centrifug
tube
ml
h
day
mice
anesthet
use
diethyl
ether
vapor
immedi
infect
influenza
viru
suspens
pb
subsequ
daili
chang
mice
surviv
bodi
weight
typic
influenza
symptom
hunch
back
ruffl
fur
alter
respir
unrespons
observ
record
day
death
consequ
data
morbid
rate
surviv
rate
calcul
second
anim
experi
also
conduct
restraintstress
mice
effect
indirubin
pneumonia
caus
influenza
viru
evalu
anim
group
first
experi
howev
five
day
post
viru
infect
weight
mice
record
subsequ
mice
anesthet
use
ether
vapor
sacrif
harvest
lung
histopatholog
examin
western
blot
analysi
inflamm
mediat
lung
weight
lung
index
count
accord
formula
lung
index
lung
weightbodi
weight
third
anim
experi
conduct
investig
effect
mechan
indirubin
type
ifn
secret
stress
mice
mice
distribut
random
four
group
normal
viru
stressviru
indirubinstressviru
indirubin
follow
treatment
second
experi
lung
tissu
collect
determin
protein
express
relat
mav
signal
cell
carcinom
human
alveolar
basal
epitheli
cell
line
cultur
dulbecco
modifi
eagl
medium
dmem
biolog
industri
ct
usa
contain
heatinactiv
fetal
bovin
serum
fb
biolog
industri
ct
usa
concentr
incub
temperatur
cell
randomli
divid
four
group
normal
viru
cortviru
indirubincortviru
cell
seed
onto
cell
cultur
dish
experi
one
day
cell
cultur
cort
cort
plu
indirubin
h
subsequ
overlaid
influenza
viru
min
pb
use
clean
cell
two
time
serumfre
dmem
ad
eight
hour
post
influenza
viru
infect
cell
collect
determin
protein
express
lung
remov
fix
paraformaldehyd
handheld
ml
syring
pump
air
lung
tissu
embed
paraffin
wax
slice
thick
slice
stain
h
e
histopatholog
chang
observ
use
object
olympu
japan
western
blot
analysi
protein
lung
sampl
cell
lysat
lyse
ripa
buffer
beyotim
shanghai
china
separ
use
sdspolyacrylamid
gel
electrophoresi
subsequ
protein
resolv
gel
transfer
polyvinyliden
fluorid
membran
millipor
usa
western
blot
visual
use
ecl
system
fdbio
scienc
hangzhou
china
quantiti
one
softwar
biorad
usa
use
analyz
intens
individu
band
data
normal
load
control
individu
sampl
follow
antibodi
use
western
blot
analysi
influenza
viru
np
rabbit
pab
rabbit
pab
rabbit
pab
rabbit
pab
provid
abcam
usa
mous
mab
mous
mab
obtain
santa
cruz
biotechnolog
ca
usa
rabbit
pab
bioworld
mn
usa
rabbit
pab
origen
technolog
md
usa
rabbit
mab
rabbit
mab
rabbit
pab
provid
cell
signal
technolog
usa
mav
rabbit
pab
sting
rabbit
pab
antibodi
obtain
proteintech
group
il
usa
cell
fix
paraformaldehyd
min
permeabil
min
either
stain
rabbit
polyclon
antibodi
np
abcam
usa
rabbit
polyclon
antibodi
mav
proteintech
group
il
usa
dilut
h
cell
incub
alexa
fluor
conjug
goat
antirabbit
igg
life
technolog
ny
usa
dilut
dapi
beyotim
shanghai
china
use
stain
cell
nuclei
cell
observ
analyz
use
confoc
laser
scan
microscop
leica
tc
germani
surflexdock
program
implement
http
bioinfopharmaustrasbgfrscpdb
use
dock
indirubin
protein
structur
scpdb
databas
http
cheminfoustrasbgfrscpdb
databas
contain
protein
structur
includ
uniqu
target
dock
perform
use
default
paramet
pgeom
mode
gaussian
shape
similar
dock
pose
cognat
ligand
also
evalu
use
shapeit
program
version
http
dock
pose
polar
score
smaller
shape
similar
tanimoto
coeffici
smaller
discard
sirna
transfect
perform
use
target
sequenc
sting
ribo
bio
guangzhou
china
nontarget
sirna
ribo
bio
guangzhou
china
use
neg
control
transfect
use
lipofectamin
invitrogen
ny
usa
carri
describ
instruct
manufactur
six
hour
transfect
cell
incub
vehicl
cort
indirubin
ad
h
cort
plu
cort
h
cell
overlaid
viru
eight
hour
later
cell
harvest
lyse
determin
protein
express
cell
cultur
glass
bottom
cell
cultur
dish
mm
nest
biotech
wuxi
china
subsequ
prepar
clontech
ca
usa
transfect
reach
confluenc
nontarget
vector
clontech
ca
usa
use
neg
control
transfect
use
lipofectamin
invitrogen
uy
usa
carri
describ
instruct
manufactur
six
hour
transfect
cell
incub
cort
cort
plu
indirubin
h
subsequ
cell
overlaid
viru
eight
hour
later
cell
stain
mav
rabbit
pab
dilut
h
stain
alexa
fluor
conjug
goat
antirabbit
igg
life
technolog
ny
usa
dilut
cell
nuclei
stain
use
dapi
beyotim
shanghai
china
fluoresc
analyz
use
confoc
laser
scan
microscop
leica
tc
germani
probe
sigma
mo
usa
use
detect
mmp
cell
harvest
cell
incub
solut
min
subsequ
cell
clean
pb
resuspend
ml
sheath
fluid
filter
nylon
mesh
cell
harvest
analyz
detect
fluoresc
emiss
use
flow
cytometri
beckman
epic
xl
usa
studi
compli
recommend
experiment
design
analysi
pharmacolog
data
express
mean
sem
least
five
differ
experi
conduct
obtain
data
statist
differ
group
estim
spss
version
usa
use
anova
multipl
comparison
tukey
posthoc
test
determin
statist
signific
surviv
curv
assess
use
kaplanmei
method
group
differ
estim
use
logrank
test
graphpad
graphpad
softwar
ca
usa
differ
consid
signific
p
valu
less
statist
test
twosid
